High-density lipoproteins: The neglected stepchildren whose importance as a risk factor continues to be defined

Clinical Chemistry

Volumn 54, Issue 5, 2008, Pages 923-924

  Warnick, G Russell ^a  

^a Berkeley HeartLab Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CHILD NEGLECT; CHOLESTEROL TRANSPORT; CLINICAL STUDY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEART INFARCTION; HUMAN; LABORATORY TEST; LIPID METABOLISM; MEDICAL RESEARCH; MONOTHERAPY; NOTE; PRACTICE GUIDELINE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; PROTEIN STRUCTURE; RISK FACTOR;

ANTICHOLESTEREMIC AGENTS; CORONARY ARTERY DISEASE; HISTORY, 20TH CENTURY; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; RISK FACTORS;

EID: 43449110740     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.097758     Document Type: Note

References (6)

1. Gofman JW, Delalla O, Flazier F, Freeman NK, Lindgren FT, Nichols AV, et al. The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease [Reprint of a 1956 Plasma paper]. J Clin Lipidol 2007;1:104-41.
2. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707-14.
3. Brown BG, Zhao, XQ, Cheung MC. Should both HDL-C and LDL-C be targets for lipid therapy? A review of current evidence. J Clin Lipidol 2007;1:88-94.
4. Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE, et al. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the veterans affairs HDL intervention trial. Arterioscler Thromb Vasc Biol 2005;25:2185-91.
5. Navab M, Anantharamaiah GM, Fogelman AM. The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med 2005;15:158-61.
6. Schaefer EJ, Asztalos BF. Cholesteryl ester transfer protein inhibition, highdensity lipoprotein metabolism and heart disease risk reduction. Curr Opin Lipidol 2006;17:394-8.